Scott Davis, MD
Family Medicine · Byram, MSNPI 1447405998
Payments from drug & device makers
Across 731 payments — averaging $14.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$1K
- Pfizer$1K
- Novo Nordisk$1K
- Boehringer Ingelheim$879
- Lilly USA, LLC$511
- plus $4K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 109 | $1,645 |
| AstraZeneca | 90 | $1,450 |
| Pfizer | 92 | $1,239 |
| Novo Nordisk | 97 | $1,225 |
| Boehringer Ingelheim | 63 | $879 |
| Lilly USA, LLC | 33 | $511 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 23 | $420 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $409 |
| Merck | 36 | $383 |
| Amarin Pharma, Inc. | 14 | $274 |
| Amgen | 15 | $225 |
| Axsome Therapeutics, Inc. | 12 | $224 |
| Idorsia Pharmaceuticals US Inc | 14 | $222 |
| GSK | 13 | $209 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $174 |
| Kowa Pharmaceuticals America, Inc. | 9 | $145 |
| Johnson & Johnson | 9 | $144 |
| Exact Sciences | 8 | $138 |
| Biohaven Pharmaceuticals, Inc. | 9 | $130 |
| Astellas Pharma US Inc | 8 | $113 |
| Sanofi-aventis U.S. LLC | 7 | $100 |
| E.r. Squibb & Sons, L.L.C. | 6 | $76 |
| Arbor Pharmaceuticals, Inc. | 5 | $67 |
| Novartis | 3 | $62 |
| Abbott | 3 | $60 |
| Nalpropion Pharmaceuticals LLC | 4 | $51 |
| Phathom Pharmaceuticals, Inc. | 3 | $50 |
| Tris Pharma Inc | 2 | $36 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Genentech USA, Inc. | 2 | $33 |
| Inari Medical, Inc. | 1 | $22 |
| Eisai Inc. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Medtronic | 1 | $15 |
| Atland Pharmaceuticals, LLC | 1 | $15 |
| Dexcom, Inc. | 1 | $11 |
How this compares
$10,825 in reported general payments places this provider in the 90th percentile of 971 family medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Byram
- Paul MatherneGulfport$14.4M
- Timothy QuinnRidgeland$8M
- Sean KerbyGulfport$6.6M
- Rambod RouhbakhshHattiesburg$6M
- Randall HulingOlive Branch$4.6M
- Demetri MarshallPort Gibson$3M
- Alexander OsowaJackson$2.2M
- Russell CarlisleWesson$1.6M
- Kristi TrimmRidgeland$1.2M
- Keith StokesLexington$660K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.